IL138292A - Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor - Google Patents

Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor

Info

Publication number
IL138292A
IL138292A IL13829299A IL13829299A IL138292A IL 138292 A IL138292 A IL 138292A IL 13829299 A IL13829299 A IL 13829299A IL 13829299 A IL13829299 A IL 13829299A IL 138292 A IL138292 A IL 138292A
Authority
IL
Israel
Prior art keywords
medicament
treating
preventing
aromatase inhibitor
mammary carcinoma
Prior art date
Application number
IL13829299A
Other languages
English (en)
Other versions
IL138292A0 (en
Original Assignee
S W Patentverwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL138292(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S W Patentverwertungs Gmbh filed Critical S W Patentverwertungs Gmbh
Publication of IL138292A0 publication Critical patent/IL138292A0/xx
Publication of IL138292A publication Critical patent/IL138292A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13829299A 1998-03-18 1999-03-03 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor IL138292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98104949A EP0943333A1 (de) 1998-03-18 1998-03-18 Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
PCT/EP1999/001374 WO1999047143A1 (de) 1998-03-18 1999-03-03 Medikament zur prophylaxe und/oder behandlung des mammakarzinoms enthaltend einen steroidalen aromataseinhibitor

Publications (2)

Publication Number Publication Date
IL138292A0 IL138292A0 (en) 2001-10-31
IL138292A true IL138292A (en) 2005-08-31

Family

ID=8231611

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13829299A IL138292A (en) 1998-03-18 1999-03-03 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor

Country Status (19)

Country Link
EP (2) EP0943333A1 (cs)
JP (1) JP4920822B2 (cs)
KR (1) KR100778803B1 (cs)
CN (1) CN1168448C (cs)
AT (1) ATE230995T1 (cs)
AU (1) AU751040B2 (cs)
BR (1) BR9908885A (cs)
CA (1) CA2324077C (cs)
CZ (1) CZ292643B6 (cs)
DE (1) DE59904042D1 (cs)
DK (1) DK1063998T3 (cs)
ES (1) ES2190201T3 (cs)
HU (1) HU226105B1 (cs)
ID (1) ID26965A (cs)
IL (1) IL138292A (cs)
PL (1) PL343100A1 (cs)
RU (1) RU2225206C2 (cs)
SK (1) SK285349B6 (cs)
WO (1) WO1999047143A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042411A1 (de) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Exemestan
DE10054294A1 (de) * 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
JP4524296B2 (ja) * 2007-03-30 2010-08-11 生化学工業株式会社 発毛促進剤
DE102007032468A1 (de) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
KR20140040690A (ko) * 2011-01-31 2014-04-03 루콜라스-엠.디. 리미티드 미용학적 용도
TR201816243T4 (tr) 2011-01-31 2018-11-21 Lucolas M D Ltd Aromataz inhibitörlerinin ve antioksidanların kombinasyonları.
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
EP3666276A1 (en) * 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
JPS6345294A (ja) * 1986-04-07 1988-02-26 Shionogi & Co Ltd アロマタ−ゼ阻害ステロイド誘導体
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
FR2656310B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
AU6391894A (en) * 1993-03-16 1994-10-11 Pfizer Inc. Naphthalene derivatives
JPH07215992A (ja) * 1993-12-07 1995-08-15 Teikoku Hormone Mfg Co Ltd ６−又は７−置換アンドロスタ−１，４−ジエン誘導体
EP0777458B1 (en) * 1994-09-14 2000-12-06 Central Sheffield University Hospitals NHS Trust Control of hair growth
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
ATE200978T1 (de) * 1996-03-29 2001-05-15 S W Patentverwertungs Ges M B KOSMETIKUM BZW. KOSMETIKZUSAMMENSETZUNG ZUR GLÄTTUNG UND STRAFFUNG DER HAUT BEI GESTÖRTEM UNTERHAUT-BINDE-FETTGEWEBE, INSBESONDERE BEI DER ßCELLULITEß
CA2632790A1 (en) * 1996-07-22 1998-01-29 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders

Also Published As

Publication number Publication date
RU2225206C2 (ru) 2004-03-10
EP0943333A1 (de) 1999-09-22
BR9908885A (pt) 2000-11-21
ID26965A (id) 2001-02-22
WO1999047143A1 (de) 1999-09-23
IL138292A0 (en) 2001-10-31
JP4920822B2 (ja) 2012-04-18
SK285349B6 (sk) 2006-11-03
HUP0101005A2 (hu) 2001-08-28
CA2324077C (en) 2008-07-29
CZ292643B6 (cs) 2003-11-12
KR100778803B1 (ko) 2007-11-27
PL343100A1 (en) 2001-07-30
EP1063998B1 (de) 2003-01-15
SK13422000A3 (sk) 2001-05-10
KR20010034603A (ko) 2001-04-25
AU751040B2 (en) 2002-08-08
HU226105B1 (en) 2008-04-28
DK1063998T3 (da) 2003-05-12
ATE230995T1 (de) 2003-02-15
CN1168448C (zh) 2004-09-29
DE59904042D1 (de) 2003-02-20
EP1063998A1 (de) 2001-01-03
CN1301165A (zh) 2001-06-27
CA2324077A1 (en) 1999-09-23
ES2190201T3 (es) 2003-07-16
AU3143499A (en) 1999-10-11
JP2002506823A (ja) 2002-03-05
CZ20003256A3 (cs) 2001-04-11

Similar Documents

Publication Publication Date Title
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
SI1556058T1 (sl) Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
IL150767A (en) Benzophyrene compounds and their use in the manufacture of drugs for the treatment of estrogen-sensitive diseases such as endometrial cancer
FR2791573B1 (fr) Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
CA2301032A1 (en) A method of preventing or treating estrogen-dependent diseases and disorders
WO2002058706A3 (en) Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
MY164077A (en) Compositions and uses of et743 for treating cancer
IL138292A (en) Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
NZ504928A (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
GB0008172D0 (en) Therapy
HUP9901633A3 (en) Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
BR0111740A (pt) Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação
AU6206698A (en) Isoflavone derivatives, processes for the preparation thereof and pharmac euticalcompositions containing them
SI1140147T1 (sl) Terapija s hcg za zdravljenje metastatskega raka na dojki
NZ337048A (en) Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer
ZA200209835B (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
WO2001036048A8 (en) Phorboxazole derivatives for treating cancer
CY1109852T1 (el) Συμπληρωμα ασβεστιου για τον περιορισμο του κινδυνου καρκινου του προστατη
AU6739690A (en) Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
IT1314187B1 (it) Combinazione di differenti composizioni farmaceutiche per iltrattamento del carcinoma mammario e relativo uso
EP1385497A4 (en) METHOD FOR PREVENTING OR TREATING BREAST CANCER, PROSTATE AND / OR COLUMN OF UTERUS USING N, N-DIMETHYLGLYCIN
AU3145400A (en) Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
NZ336321A (en) Use of benzothiophene (raloxifene) for treating breast cancer
NZ516564A (en) Cancer therapy

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
KB Patent renewed
EXP Patent expired